[1]张 辉,张 颖.多奈哌齐联合司来吉兰对阿尔茨海默病患者认知功能及不良反应的影响[J].医学信息,2022,35(13):110-112.[doi:10.3969/j.issn.1006-1959.2022.13.024]
　ZHANG Hui,ZHANG Ying.Effect of Donepezil Combined with Selegilan on Cognitive Function and Adverse Reactions in Patients with Alzheimer’s Disease[J].Medical Information,2022,35(13):110-112.[doi:10.3969/j.issn.1006-1959.2022.13.024]
点击复制

多奈哌齐联合司来吉兰对阿尔茨海默病患者认知功能及不良反应的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年13期
页码:
110-112
栏目:
论著
出版日期:
2022-07-01

文章信息/Info

Title:
Effect of Donepezil Combined with Selegilan on Cognitive Function and Adverse Reactions in Patients with Alzheimer’s Disease
文章编号:
1006-1959（2022）13-0110-03
作者:
张 辉; 张 颖
（解放军联勤保障部队第九八三医院干部病房一科1，急诊科2，天津 300014）
Author(s):
ZHANG Hui; ZHANG Ying
(The First Cadre Ward1,Emergency Department2,The 983 Hospital of the PLA Joint Logistic Support Force,Tianjin 300014,China)
关键词:
阿尔茨海默病; 多奈哌齐; 司来吉兰; 认知功能
Keywords:
Alzheimer’s disease; Donepezil; Selegiline; Cognitive function
分类号:
R749.1+6
DOI:
10.3969/j.issn.1006-1959.2022.13.024
文献标志码:
A
摘要:
目的 探究多奈哌齐联合司来吉兰对阿尔茨海默病（AD）患者认知功能及不良反应的影响。方法 选取2019年7月-2021年1月解放军联勤保障部队第九八三医院收治的98例AD患者，依据随机数字表法分为对照组与观察组，各49例。对照组给予多奈哌齐治疗，观察组应用多奈哌齐联合司来吉兰治疗，比较两组AD评定量表（ADAS）评分、长谷川痴呆量表（HDS）评分、蒙特利尔认知评估量表（MoCA）评分、简易精神状态检查量表（MMSE）评分、血清生化指标[β样淀粉蛋白（Aβ）、超氧化物歧化酶（SOD）、丙二醛（MDA）]及不良反应情况。结果 观察组治疗后ADAS评分低于对照组，HDS评分高于对照组，差异有统计学意义（P＜0.05）；两组MoCA、MMSE评分均高于治疗前，且观察组高于对照组，差异有统计学意义（P＜0.05）；观察组治疗后Aβ、MDA水平低于对照组，SOD水平高于对照组，差异有统计学意义（P＜0.05）；观察组不良反应发生率为12.24%，与对照组的8.16%比较，差异无统计学意义（P＞0.05）。结论 多奈哌齐联合司来吉兰可有效减轻AD患者的病情程度，改善其认知功能，降低氧化应激指标，且不增加不良反应风险。
Abstract:
Objective To explore the effects of donepezil combined with selegiline on cognitive function and adverse reactions in patients with Alzheimer’s disease (AD).Methods A total of 98 AD patients admitted to the 983 Hospital of the PLA Joint Logistic Support Force from July 2019 to January 2021 were selected and divided into the control group and the observation group according to the random number table method, with 49 cases in each group. The control group was treated with donepezil, while the observation group was treated with donepezil combined with selegiline. The scores of Alzheimer’s disease assessment scale (ADAS), Hasegawa dementia scale (HDS), Montreal cognitive assessment scale (MoCA), mini mental state examination scale (MMSE), serum biochemical indexes [β-amyloid protein (Aβ), superoxide dismutase (SOD), malondialdehyde (MDA)] and adverse reactions were compared between the two groups.Results After treatment, the ADAS score of the observation group was lower than that of the control group, and the HDS score was higher than that of the control group, the difference was statistically significant (P<0.05).The MoCA and MMSE scores of the two groups were higher than those before treatment, and the observation group was higher than the control group, the difference was statistically significant (P<0.05). After treatment, the levels of Aβ and MDA in the observation group were lower than those in the control group, and the SOD level was higher than that in the control group, the difference was statistically significant(P<0.05). The incidence of adverse reactions in the observation group was 12.24%, which was compared with 8.16% in the control group, the difference was not statistically significant(P＞0.05).Conclusion Donepezil combined with selegilan can effectively reduce the severity of AD patients, improve their cognitive function, reduce oxidative stress indexes, and do not increase the risk of adverse reactions.

参考文献/References:

[1]郑芳芳,陈士华,闻传毅,等.多奈哌齐联合叶酸、维生素B12治疗对老年阿尔茨海默病伴高同型半胱胺酸血症患者血清炎性因子、HCY、NSE及脑神经递质的影响[J].海南医学院学报,2017,23(16):2274-2277.[2]李瑞天,赵园园,蔡灵钰,等.盐酸多奈哌齐对阿尔茨海默病患者认知功能及氧化应激水平的影响[J].中国医药,2020,15(3):382-385.[3]陈科.盐酸多奈哌齐治疗阿尔茨海默病的临床研究[J].中国临床药理学杂志,2016,32(11):981-983.[4]Nobili A,Latagliata EC,Viscomi MT,et al.Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease[J].Nature Communications,2017,8(1):362-381.[5]田金洲,解恒革,王鲁宁,等.中国阿尔茨海默病痴呆诊疗指南(2020年版)[J].中华老年医学杂志,2021,40(3):269-283.[6]刘得伟,许俊华,张东风,等.叶酸、维生素B12联合多奈哌齐对阿尔茨海默病患者认知功能及精神行为症状的影响[J].国际精神病学杂志,2020,47(1):101-103.[7]马雅军,李晓东,胡志灏,等.老年人认知功能和跌倒的关系研究[J].中国全科医学,2019,22(15):1784-1788.[8]唐煜,郝单单,秦玮婷,等.轻度阿尔茨海默病患者年龄对蒙特利尔认知评估量表基本版得分的影响[J].首都医科大学学报,2019,40(4):652-655.[9]王阳,徐冰,周进,等.司来吉兰联合普拉克索对帕金森病合并睡眠障碍患者精神行为症状认知障碍及日常生活能力的影响[J].河北医学,2019,25(7):1078-1081.[10]程度,晁志文,何远宏,等.多奈哌齐联合喹硫平对阿尔茨海默病患者的认知功能和精神症状的疗效[J].国际精神病学杂志,2019,46(3):477-480.[11]崔凯,张勤,陈淅泠.多奈哌齐联合盐酸美金刚治疗阿尔茨海默病的临床疗效[J].中国老年学杂志,2019,39(4):868-870.[12]张建强,高红安,宋程光,等.酒石酸卡巴拉汀联合盐酸多奈哌齐对阿尔茨海默病病人轻度认知功能障碍的影响[J].中西医结合心脑血管病杂志,2017,15(3):368-370.[13]孙国兵,付斌,谭倩,等.丁苯酞联合多奈哌齐对阿尔茨海默病患者认知功能及脑血管储备功能的影响[J].疑难病杂志,2018,17(8):781-785,865.[14]Ceyzériat K,Gloria Y,Millet P,et al.Connectivity between serotonin and dopamine systems is altered in Alzheimer’s disease: Molecular and cell biology/others[J].Alzheimer’s and Dementia,2020,16(S3):179-185.[15]李满红,李满连.苯海索联合司来吉兰对帕金森病患者血清学指标及认知功能的影响[J].临床合理用药杂志,2021,14(3):46-48.[16]张俊霞,金俏,侯倩,吴世政.低频经颅磁刺激联合司来吉兰对中晚期帕金森病患者运动功能的影响[J].中国康复医学杂志,2017,32(7):831-832.[17]曾庆银.盐酸司来吉兰联合美多巴对帕金森病患者神经功能及日常活动能力的影响[J].临床医学,2017,37(8):101-103.[18]付勇.多奈哌齐联合司来吉兰对帕金森病患者氧化应激水平及认知功能的影响[J].社区医学杂志,2018,16(4):15-17.[19]陈曦,马婷,张梓宸.盐酸多奈哌齐片联合司来吉兰片治疗帕金森病的效果观察[J].黑龙江医药科学,2018,41(4):78-79.[20]Wei M,Liu Y,Pi Z,et al.Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35[J].RSC Advances,2019,9(32):18308-18319.

相似文献/References:

[1]刘 璐,秦新月.阿尔茨海默病患者血尿酸水平变化的研究[J].医学信息,2018,31(02):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
　LIU Lu,QIN Xin-yue.Study on the Changes of Serum Uric Acid in Alzheimer 's Disease Patients[J].Medical Information,2018,31(13):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
[2]赖 超,成官迅.rs-fMRI、DTI及1H-MRS在阿尔茨海默病中的应用进展[J].医学信息,2018,31(13):41.[doi:10.3969/j.issn.1006-1959.2018.13.013]
　LAI Chao,CHENG Guan-xun.Application of rs-fMRI、DTI and 1H-MRS in Alzheimer’s Disease[J].Medical Information,2018,31(13):41.[doi:10.3969/j.issn.1006-1959.2018.13.013]
[3]唐娟娟,高春岭,秦凤琴.蒙特利尔认知评估量表在成都市郫都区老年性痴呆筛查中的应用分析[J].医学信息,2018,31(19):12.[doi:10.3969/j.issn.1006-1959.2018.19.004]
　TANG Juan-juan,GAO Chun-ling,QIN Feng-qin.Application Analysis of Montreal Cognitive Assessment Scale in Screening for Alzheimer’s Disease in Pidu District,Chengdu[J].Medical Information,2018,31(13):12.[doi:10.3969/j.issn.1006-1959.2018.19.004]
[4]秦亚东.多奈哌齐联合阿米替林治疗神经衰弱伴发认知障碍患者的临床效果[J].医学信息,2019,32(10):144.[doi:10.3969/j.issn.1006-1959.2019.10.047]
　QIN Ya-dong.Clinical Effect of Donepezil Combined with Amitriptyline in the Treatment of Patients with Neurasthenia and Cognitive Impairment[J].Medical Information,2019,32(13):144.[doi:10.3969/j.issn.1006-1959.2019.10.047]
[5]杨联勇,沈金娥.阿尔茨海默病新药的临床实验研究[J].医学信息,2020,33(02):50.[doi:10.3969/j.issn.1006-1959.2020.02.014]
　YANG Lian-yong,SHEN Jin-e.Clinical Experimental Study of New Drugs for Alzheimer’s Disease[J].Medical Information,2020,33(13):50.[doi:10.3969/j.issn.1006-1959.2020.02.014]
[6]康晨瑶,刘 洲,周海红.NLRP3炎症小体在AD发病机制中的作用[J].医学信息,2021,34(12):40.[doi:10.3969/j.issn.1006-1959.2021.12.011]
　KANG Chen-yao,LIU Zhou,ZHOU Hai-hong.The Role of NLRP3 Inflammasome in the Pathogenesis of AD[J].Medical Information,2021,34(13):40.[doi:10.3969/j.issn.1006-1959.2021.12.011]
[7]韦春英,莫颖敏.阿尔茨海默病早期诊断的脑脊液和血液生物标志物研究[J].医学信息,2021,34(14):25.[doi:10.3969/j.issn.1006-1959.2021.14.007]
　WEI Chun-ying,MO Ying-min.Study on Cerebrospinal Fluid and Blood Biomarkers for Early Diagnosis of Alzheimer’s Disease[J].Medical Information,2021,34(13):25.[doi:10.3969/j.issn.1006-1959.2021.14.007]
[8]张 瑞,延沁儒.丹酚酸B调节Bax/Bcl-2的表达对阿尔茨海默病小鼠认知功能的影响及机制[J].医学信息,2021,34(17):70.[doi:10.3969/j.issn.1006-1959.2021.17.018]
　ZHANG Rui,YAN Qin-ru.Effects of Salvianolic Acid B on the Cognitive Function of Alzheimer’s Disease Mice and its Mechanism Regulating the Expression of Bax/Bcl-2[J].Medical Information,2021,34(13):70.[doi:10.3969/j.issn.1006-1959.2021.17.018]
[9]徐 静.综合康复护理对阿尔兹海默病患者认知功能及生活能力的影响[J].医学信息,2023,36(04):150.[doi:10.3969/j.issn.1006-1959.2023.04.031]
　XU Jing.Effect of Comprehensive Rehabilitation Nursing on Cognitive Function and Living Ability of Patients with Alzheimer’s Disease[J].Medical Information,2023,36(13):150.[doi:10.3969/j.issn.1006-1959.2023.04.031]
[10]陈浩宇,张 淼,张德锦,等.基于数据挖掘技术分析穴位按摩治疗阿尔茨海默病的选穴规律[J].医学信息,2023,36(08):7.[doi:10.3969/j.issn.1006-1959.2023.08.002]
　CHEN Hao-yu,ZHANG Miao,ZHANG De-jin,et al.Analysis of Acupoint Selection Rules in Treating Alzheimer’s Disease with Acupoint Massage Based on Data Mining[J].Medical Information,2023,36(13):7.[doi:10.3969/j.issn.1006-1959.2023.08.002]
[11]于京虎.复方脑肽节苷脂联合多奈哌齐对阿尔茨海默病患者认知功能及SOD水平的影响[J].医学信息,2023,36(03):148.[doi:10.3969/j.issn.1006-1959.2023.03.031]
　YU Jing-hu.Effect of Compound Porcine Cerebroside and Ganglioside Combined with Donepezil on Cognitive Function and SOD Level in Patients with Alzheimer’s Disease[J].Medical Information,2023,36(13):148.[doi:10.3969/j.issn.1006-1959.2023.03.031]

更新日期/Last Update: 1900-01-01